Common Contracts
5 similar Change in Control and Severance Agreement contracts by Morphic Holding, Inc.
Change in Control and Severance AgreementChange in Control and Severance Agreement • April 29th, 2021 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
This Change in Control and Severance Agreement (the “Agreement”) is entered into by and between Peter Linde (the “Executive”) and Morphic Holding, Inc., a Delaware corporation (the “Company”) 1, and is effective as of the Effective Date.
CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • August 10th, 2020 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
This Change in Control and Severance Agreement (the “Agreement”) is entered into by and between Marc Schegerin, M.D. (the “Executive”) and Morphic Holding, Inc., a Delaware corporation (the “Company”) 1, and is effective as of the Effective Date.
CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • June 14th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
This Change in Control and Severance Agreement (the “Agreement”) is entered into by and between Bruce Rogers (the “Executive”) and Morphic Holding, Inc., a Delaware corporation (the “Company”)1, and is effective as of the Effective Date.
CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • June 14th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
This Change in Control and Severance Agreement (the “Agreement”) is entered into by and between Praveen Tipirneni, MD, (the “Executive”) and Morphic Holding, Inc., a Delaware corporation (the “Company”)1, and is effective as of the Effective Date.
CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • June 14th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
This Change in Control and Severance Agreement (the “Agreement”) is entered into by and between Alexey A. Lugovskoy, Ph.D. (the “Executive”) and Morphic Holding, Inc., a Delaware corporation (the “Company”)1, and is effective as of the Effective Date.
